Encapsulation of Upconversion Nanoparticles in Periodic Mesoporous Organosilicas

上转换纳米粒子在周期性介孔有机硅中的封装

阅读:1

Abstract

(1) Background: Nanomedicine has recently emerged as a promising field, particularly for cancer theranostics. In this context, nanoparticles designed for imaging and therapeutic applications are of interest. We, therefore, studied the encapsulation of upconverting nanoparticles in mesoporous organosilica nanoparticles. Indeed, mesoporous organosilica nanoparticles have been shown to be very efficient for drug delivery, and upconverting nanoparticles are interesting for near-infrared and X-ray computed tomography imaging, depending on the matrix used. (2) Methods: Two different upconverting-based nanoparticles were synthesized with Yb(3+)-Er(3+) as the upconverting system and NaYF(4) or BaLuF(5) as the matrix. The encapsulation of these nanoparticles was studied through the sol-gel procedure with bis(triethoxysilyl)ethylene and bis(triethoxysilyl)ethane in the presence of CTAB. (3) Results: with bis(triethoxysilyl)ethylene, BaLuF(5): Yb(3+)-Er(3+), nanoparticles were not encapsulated, but anchored on the surface of the obtained mesoporous nanorods BaLuF(5): Yb(3+)-Er(3+)@Ethylene. With bis(triethoxysilyl)ethane, BaLuF(5): Yb(3+)-Er(3+) and NaYF(4): Yb(3+)-Er(3+)nanoparticles were encapsulated in the mesoporous cubic structure leading to BaLuF(5): Yb(3+)-Er(3+)@Ethane and NaYF(4): Yb(3+)-Er(3+)@Ethane, respectively. (4) Conclusions: upconversion nanoparticles were located on the surface of mesoporous nanorods obtained by hydrolysis polycondensation of bis(triethoxysilyl)ethylene, whereas encapsulation occurred with bis(triethoxysilyl)ethane. The later nanoparticles NaYF(4): Yb(3+)-Er(3+)@Ethane or BaLuF(5): Yb(3+)-Er(3+)@Ethane were promising for applications with cancer cell imaging or X-ray-computed tomography respectively.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。